Life ScienceCompany
Merrimack Pharmaceuticals - Oncology Assets Ownership
Who owns Merrimack Pharmaceuticals - Oncology Assets?
Merrimack Pharmaceuticals - Oncology Assets is owned by Ipsen SA. It was acquired on January 8, 2017.
Merrimack Pharmaceuticals - Oncology Assets Business Overview
Where is Merrimack Pharmaceuticals - Oncology Assets headquartered?
Merrimack Pharmaceuticals - Oncology Assets is headquartered in Cambridge, Massachusetts.
What sector is Merrimack Pharmaceuticals - Oncology Assets in?
Merrimack Pharmaceuticals - Oncology Assets is a life science company.
Life Science M&A Summary in 2017
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.
Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.